Dioxane

Dioxane

SCHEMBL28146643

C1COCCO1.Cc1ccc(OP(=O)(Oc2ccc(C)cc2)Oc2ccc(C)cc2)cc1

nearest known ligand 0.76

Full drug profile on Sugi Atlas →

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 3/20 0.76
▸ TSHR P16473 2/20 0.76
▸ ALDH1A1 P00352 2/20 0.47
▸ MAPK1 P28482 1/20 0.47
▸ TDP1 Q9NUW8 1/20 0.47
▸ CYP1A2 P05177 2/20 0.45
▸ CYP2C9 P11712 2/20 0.45
▸ CYP2C19 P33261 2/20 0.45
▸ MEN1 O00255 6/20 0.40
▸ KMT2A Q03164 6/20 0.40
▸ LMNA P02545 2/20 0.40
▸ MAPT P10636 1/20 0.40
▸ NPSR1 Q6W5P4 1/20 0.39
▸ USP2 O75604 1/20 0.39
▸ HPGD P15428 1/20 0.39
▸ FKBP1A P62942 1/20 0.39
▸ HSP90AA1 P07900 1/20 0.38
▸ GAA P10253 1/20 0.38
▸ ACHE P22303 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tetrahydrofuran SCHEMBL11598440 0.91 CYP3A4 (0.68) CYP3A4TSHRALDH1A1MAPK1TDP1
SCHEMBL131412 0.87 TSHR (1.00) CYP3A4TSHRALDH1A1MAPK1TDP1
SCHEMBL21582 0.87 TSHR (1.00) CYP3A4TSHRALDH1A1MAPK1TDP1
SCHEMBL10336991 0.87 TSHR (1.00) CYP3A4TSHRALDH1A1MAPK1TDP1
SCHEMBL27393883 0.87 TSHR (1.00) CYP3A4TSHRALDH1A1MAPK1TDP1
SCHEMBL27371282 0.87 TSHR (1.00) CYP3A4TSHRALDH1A1MAPK1TDP1
SCHEMBL8331868 0.85 TSHR (0.95) CYP3A4TSHRALDH1A1MAPK1TDP1
SCHEMBL28869386 0.85 TSHR (0.95) CYP3A4TSHRALDH1A1MAPK1TDP1
SCHEMBL9785893 0.85 CYP3A4 (0.95) CYP3A4TSHRALDH1A1MAPK1TDP1
Water SCHEMBL29287558 0.85 TSHR (0.95) CYP3A4TSHRALDH1A1MAPK1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106795117-A Heterobicyclic compounds and their use for the treatment of tuberculosis 大塚制药株式会社 2017-05-31 — — CN disclosed
Send feedback